Valuation (47%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 28.03 | 17.75 |
| PEG Ratio (TTM) | 3.28 | 2.31 |
| P/S Ratio (TTM) | 1.61 | 3.96 |
| P/B Ratio (TTM) | 1.63 | 2.15 |
| P/FCF Ratio (TTM) | -17.35 | -1.81 |
| Price to 5YR AVG Earnings Ratio | 23.04 | 9.11 |
| Price to 5YR AVG FCF Ratio | 41.39 | -193.92 |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.92% | 1.13% |
| ROE (TTM) | 5.92% | 11.77% |
| Net Profit Margin (TTM) | 5.98% | 20.55% |
| ROIC 5YR AVG | 7.65% | 14.81% |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 24.72% | 204.13% | 99.59% |
| Revenue | 22.65% | 37.62% | 20.86% |
| Net Income | 23.99% | 201.33% | 97.25% |
| Cash Flow | -342.58% | -191.14% | -153.17% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.91 | 3.36 |
| Quick Ratio (TTM) | 0.91 | 3.28 |
| D/E Ratio (TTM) | 1.46 | 2.71 |
| Interest Coverage (TTM) | 1.22 | 1.72 |
| Piotroski F-Score | 4 | 4 |
| Altman Z-Score | 0.70 | 1.18 |
| LTL to 5YR AVG FCF | 39.91 | -292.74 |
| Shares Outstanding Growth 5YR AVG | -5.37% | 1.49% |